COMPANY OVERVIEW

Nimbus Therapeutics is a biotechnology company pioneering the application of highly-advanced computational technologies to the design and development of novel treatments for substantial and underserved human diseases.

---

LOCATION

Cambridge, MA, USA

---

THERAPEUTIC AREAS

Inflammatory Disease

Metabolic Disorders

Oncology

---

WEBSITE

https://www.nimbustx.com

---

CAREER WEBSITE

https://www.nimbustx.com/join-us/

---

SOCIAL MEDIA

---

INVESTORS

---

---

PRESS RELEASES

Sep 6, 2023

Nimbus Therapeutics Secures $210M Private Financing to Advance Next Wave of Tech-Enabled Small Molecule Medicines

Feb 8, 2023

Nimbus Therapeutics Announces Closing of Takeda’s Acquisition of TYK2 Subsidiary

Feb 8, 2023

Takeda Completes Acquisition of Nimbus Therapeutics’ TYK2 Program Subsidiary

Dec 13, 2022

Takeda to Acquire Nimbus Therapeutics’ Highly Selective, Allosteric TYK2 Inhibitor to Address Multiple Immune-Mediated Diseases

Dec 13, 2022

Takeda to Acquire Late-Stage, Potential Best-in-Class, Oral Allosteric TYK2 Inhibitor NDI-034858 From Nimbus Therapeutics

For More Press Releases

---